Retrieve all available abstracts of the following 315 articles: HTML format
Single Articles
PO J, Bookstein A, Lee W, Barahona R, et al Assessing impact of a community-based screening campaign to address social
determinants of cervical cancer.
JNCI Cancer Spectr. 2025 Jan 31:pkaf006. doi: 10.1093. PubMed Abstract available
GORVEL L, Panouillot M, Rouviere MS, Billon E, et al Tertiary lymphoid structures are associated with enhanced macrophage activation
and immune checkpoint expression, and predict outcome in cervical cancer.
Cancer Immunol Res. 2025 Jan 31. doi: 10.1158/2326-6066.CIR-24-0979. PubMed Abstract available
OGASAWARA A, Hasegawa K Recent advances in immunotherapy for cervical cancer.
Int J Clin Oncol. 2025 Jan 31. doi: 10.1007/s10147-025-02699. PubMed Abstract available
PASHA A, Ravinder D, Pawar SC Andrographolide Mitigates Cisplatin Resistance by Inhibiting SPP1 Regulated
NF-kB/iNOS/COX-2 and PI3K/AKT Pathway in Cisplatin Resistant Cervical Carcinoma
Cells.
Drug Dev Res. 2025;86:e70052. PubMed Abstract available
RETRACTION: Promotion of Cell Autophagy and Apoptosis in Cervical Cancer by
Inhibition of Long Noncoding RNA LINC00511 via Transcription Factor
RXRA-regulated PLD1.
J Cell Physiol. 2025;240:e31527. PubMed Abstract available
CAO DM, Rao Y, Liu T, Yuan WQ, et al Combination of Metabolomics and Bioinformatics to Reveal the Mechanism of
Luteolin in the Treatment of Cervical Cancer.
Chem Biol Drug Des. 2025;105:e70059. PubMed Abstract available
DENNY L Cervical cancer screening using tests that provide same-day results: a study of
test accuracy.
BMJ Oncol. 2024;3:e000234. PubMed
LEE SM, Shin D, Seol A, Lee S, et al Diabetes Is Positively Associated With High Risk of Depression in Korean Cervical
Cancer Patients: Korean National Health and Nutrition Examination Survey
2010-2021.
Psychiatry Investig. 2025;22:57-65. PubMed Abstract available
TANAKA Y ASO Author Reflections: Tackling the Unresolved Topic: Impact of Adjuvant
Chemotherapy on Survival in Patients with Surgically Treated Uterine Cervical
Cancer.
Ann Surg Oncol. 2025 Jan 30. doi: 10.1245/s10434-025-16935. PubMed
BRUN JL, Bergeron C, Averous G, Ardaens K, et al [Management of women with abnormal cervical cytology: Update of INCa
recommendations after the implementation of HPV screening].
Gynecol Obstet Fertil Senol. 2025;53:54-75. PubMed Abstract available
POHL AL, Aderonmu AA, Grab JD, Cohen-Tigor LA, et al Transportation Insecurity, Social Support, and Adherence to Cancer Screening.
JAMA Netw Open. 2025;8:e2457336. PubMed Abstract available
OMOLE OB, Francis JM, Musonda JM, Sodo PP, et al High burden of abnormal cervical smears in South African primary health care:
health programmes implications.
Health Promot Int. 2025;40:daae162. PubMed Abstract available
WU YX, Chen YC, Jhuang JR, Chiang CJ, et al Emerging trends in cervical cancer incidence among younger Taiwanese generations:
an urban-rural comparison.
Ann Med. 2025;57:2458765. PubMed Abstract available
SHI F, Wei Y, Huang Y, Yao D, et al Activating Transcription Factor 5 Promotes Tumorigenic Capability in Cervical
Cancer Through the Wnt/beta-Catenin Signaling Pathway.
Cancer Manag Res. 2025;17:131-143. PubMed Abstract available
LAVARINI CALAZANS MOURA A, Vale Bayao G, Celestino Da Silva N, Batista Palma G, et al Knowledge, attitude and practice of physical therapists in the care of women
undergoing treatment for cervical cancer: a survey of practice in Brazil.
Physiother Theory Pract. 2025 Jan 30:1-9. doi: 10.1080/09593985.2025.2456515. PubMed Abstract available
CHIRIKOVA E, Dorismond V, Cortella AM, DeRouen MC, et al The impact of age at initial HPV vaccination on cervical cancer screening
participation in a nationally representative cohort of women in the United
States.
J Med Screen. 2025 Jan 30:9691413251315879. doi: 10.1177/09691413251315879. PubMed Abstract available
DONG P, Xiong Y, Yu J, Chen L, et al Editorial Expression of Concern: Control of PD-L1 expression by
miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in
cervical cancer.
Oncogene. 2025 Jan 29. doi: 10.1038/s41388-025-03285. PubMed
ZHANG T, Yan P, Wong CL, Huang Z, et al Psychological resilience, dyadic coping, and dyadic adjustment in couples dealing
with cervical cancer in Northwest China: A cross-sectional study.
Eur J Oncol Nurs. 2025;74:102785. PubMed Abstract available
SHEN Q, Qiu L, Zhou Y, Wang L, et al Pan-cancer analysis of DCBLD1 and its association with the diagnosis,
immunotherapy, and prognosis of cervical cancer.
Int Immunopharmacol. 2025;148:114167. PubMed Abstract available
COSTA ACO, Faria Junior JG, Oliveira GL, Ramos DO, et al Material deprivation, racial inequalities and mortality from female breast,
prostate, and cervical neoplasm in the Brazilian adult population: an ecological
study.
Cien Saude Colet. 2025;30:e02212024. PubMed Abstract available
VINSON AH, Norrid C, Haro EK, Ernst S, et al Cervical Cancer Screening in Women With Physical Disabilities.
JAMA Netw Open. 2025;8:e2457290. PubMed Abstract available
SRIPAN P, Proute M, Ngo-Giang-Huong N, Rangdaeng S, et al Evaluation of cervical cancer screening strategies in women living with HIV in
Thailand.
Cancer Commun (Lond). 2025 Jan 29. doi: 10.1002/cac2.70000. PubMed
LV Z, He X, Li Z, Yuan Y, et al Outcomes and associated factors of cervical human papillomavirus infection among
608 women in Shenzhen, China, 2018-2023.
Front Public Health. 2025;12:1523839. PubMed Abstract available
DO NASCIMENTO GR, da Silva Santos AC, Silva NNT, Guilmaraes NS, et al Prevalence of non-vaccine high-risk HPV cervical infections in vaccinated women:
a systematic review and meta-analysis.
BMC Infect Dis. 2025;25:131. PubMed Abstract available
PALACIOS RODRIGUEZ OA, Galarde Lopez M, Quezada Sanchez C, Reyna Sevilla A, et al Spatial Epidemiology of Human Papillomavirus Screening Coverage in Mexico,
2013-2019.
Asian Pac J Cancer Prev. 2025;26:215-224. PubMed Abstract available
MEZZOUG N, Meski FZ, Khay EO, Skali Senhaji N, et al Breaking Barriers in Cancer Screening: Understanding Participant Dropout in
Breast and Cervical Programs in Morocco.
Asian Pac J Cancer Prev. 2025;26:67-75. PubMed Abstract available
PRAKASH A, Patel Y, Roy JK BRN3A, a transcription factor, regulates the expression of genes involved in
biological processes shaping the HPV induced cervical cancer.
Genes Genomics. 2025 Jan 28. doi: 10.1007/s13258-025-01620. PubMed Abstract available
ADLER D, Wood N, Fiscella K, Mustian K, et al Low-cost interventions to increase uptake of cervical cancer screening among
emergency department patients: Results of a randomized clinical trial.
Acad Emerg Med. 2025 Jan 28. doi: 10.1111/acem.15101. PubMed Abstract available
MIZUNO S, Okayama K, Misawa Y, Honda S, et al Vacuolated Parabasal Cells in Papanicolaou Smears Are Cellular Changes Caused by
Human Papillomavirus 16 Infection.
J Med Virol. 2025;97:e70191. PubMed Abstract available
ENDALE S, Delelegn K, Negash Z Knowledge, attitude, practices, and associated factors toward cervical cancer
among female health sciences students of Addis Ababa University, Addis Ababa,
Ethiopia.
Ther Adv Vaccines Immunother. 2025;13:25151355251314733. PubMed Abstract available
XU Y, Li C, Cheng L, Wang S, et al Prognostic and diagnostic value of circRNA expression in cervical cancer: a meta
analysis.
Front Oncol. 2025;14:1488040. PubMed Abstract available
LI Y, Zhang H, Xin W, Qin T, et al Adenoviral Therapy for Cervical Cancer: From Targeted Modification to
Immunotherapy.
Anticancer Agents Med Chem. 2025. PubMed Abstract available
HADDAD MA, Zare Mehrabadi F, Hosseini Motlagh NS, Zarei Mahmoudabadi M, et al Graphene oxide-enhanced photothermal therapy: laser parameter optimization and
temperature modeling for hela cancer cell mortality.
Lasers Med Sci. 2025;40:50. PubMed Abstract available
OU Q, Tang J, Zhang Y, Gan S, et al The combined immunization of cervical cancer therapeutic vaccine based on
Listeria balanced lethal system has a significant therapeutic effect on tumor
model mice.
Int Immunopharmacol. 2025;148:114124. PubMed Abstract available
YANG CY, Chang TC, Lee YT, Shih TY, et al Exploring the Interplay Between Cervicovaginal Microbiome, HPV Infection, and
Cervical Intraepithelial Neoplasia in Taiwanese Women.
J Med Virol. 2025;97:e70190. PubMed Abstract available
ZHANG J, Shen Q, Xia L, Zhu X, et al Corrigendum: DYNLT3 overexpression induces apoptosis and inhibits cell growth and
migration via inhibition of the Wnt pathway and EMT in cervical cancer.
Front Oncol. 2025;14:1545180. PubMed Abstract available
LIU J, Zhang Q, He L, Hu H, et al Pan-Cancer Analysis Identifies YKT6 as a Prognostic and Immunotherapy Biomarker,
with an Emphasis on Cervical Cancer.
Onco Targets Ther. 2025;18:107-127. PubMed Abstract available
CHEN YP, Chiu CF, Wang CN, Lin CC, et al Conglomerated Imiquimod and Metronidazole Incorporated Biodegradable Nanofibrous
Mats for Potential Therapy of Cervical Cancer.
Int J Nanomedicine. 2025;20:951-966. PubMed Abstract available
FIGUEROA-ANGULO EE, Puente-Rivera J, Perez-Navarro YF, Condado EM, et al Epigenetic alteration in cervical cancer induced by human papillomavirus.
Int Rev Cell Mol Biol. 2025;390:25-66. PubMed Abstract available
CELIK N, Saruhan A The experiences of women diagnosed with precancerous cervical lesions, and their
spouses, according to the Roy Adaptation Model: Model-based qualitative research.
Appl Nurs Res. 2025;81:151894. PubMed Abstract available
GRUBER K India is boosting vaccination efforts to eradicate cervical cancer.
Lancet Oncol. 2025 Jan 23:S1470-2045(25)00022. PubMed
HAO F, Yan Z, Shen L, Hui W, et al Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve
prognosis in ovarian and cervical cancers.
J Ovarian Res. 2025;18:14. PubMed Abstract available
ZHANG Y, Ning C, Yang W An automatic cervical cell classification model based on improved DenseNet121.
Sci Rep. 2025;15:3240. PubMed Abstract available
BOJE RB, Bardou M, Mensah K, Rico Berrocal R, et al How can cervical screening meet the needs of vulnerable women? A qualitative
comparative study with stakeholder perspectives from seven European countries.
BMJ Open. 2025;15:e090631. PubMed Abstract available
DAI Y, Lu S, Wei L, Liu L, et al Targeted Delivery of SmacN7 Peptide Induces Immunogenic Cell Death in Cervical
Cancer Treatment.
Appl Biochem Biotechnol. 2025 Jan 25. doi: 10.1007/s12010-024-05129. PubMed Abstract available
EINBOND LS, Zhou J, Huang K, Castellanos MR, et al Plant Compounds Inhibit the Growth of W12 Cervical Precancer Cells Containing
Episomal or Integrant HPV DNA; Tanshinone IIA Synergizes with Curcumin in
Cervical Cancer Cells.
Viruses. 2024;17:55. PubMed Abstract available
MARKOWSKA A, Antoszczak M, Markowska J, Huczynski A, et al Role of Epigallocatechin Gallate in Selected Malignant Neoplasms in Women.
Nutrients. 2025;17:212. PubMed Abstract available
HALAS-WISNIEWSKA M, Arendt W, Grzanka A, Izdebska M, et al Downregulation of Ezrin Suppresses Migration Potential in Cervical Cancer Cells.
Pharmaceuticals (Basel). 2024;18:3. PubMed Abstract available
LIU W, Lu J, Li J, Wang L, et al Gboxin Induced Apoptosis and Ferroptosis of Cervical Cancer Cells by Promoting
Autophagy-Mediated Inhibition of Nrf2 Signaling Under Low-Glucose Conditions.
Int J Mol Sci. 2025;26:502. PubMed Abstract available
SUH YJ, Lee DH, Lee HJ, Lee B, et al Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation Versus Adjuvant
Chemotherapy Following Concurrent Chemoradiation for Locally Advanced Cervical
Cancer: A Network Meta-Analysis.
Cancers (Basel). 2025;17:223. PubMed Abstract available
CHEUNG ES, Wu PY Current Paradigm and Future Directions in the Management of Nodal Disease in
Locally Advanced Cervical Cancer.
Cancers (Basel). 2025;17:202. PubMed Abstract available
MOLNAR O, Mihutiu S, Straciuc OM, Vesa A, et al PET CT Imaging with FDG in the Therapeutical Management of Locally Advanced
Cervical Cancer Diagnosed in a 43-Year-Old Patient: Case Report and Review of the
Literature.
Biomedicines. 2025;13:83. PubMed Abstract available
BUALOY W, Sumdaengrit B, Junda T, Lertkhachonsuk AA, et al Factors Predicting Sexual Satisfaction of Thai Women with Cervical Cancer After
Complete Treatment at Least One Year and Their Spouses.
Healthcare (Basel). 2025;13:112. PubMed Abstract available
PU M, Xiao X, Lv S, Ran D, et al METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by
inactivating the Hippo/YAP signaling.
Hereditas. 2025;162:9. PubMed Abstract available
LI G, Fan X, Xu C, Lv P, et al Detection of cervical cell based on multi-scale spatial information.
Sci Rep. 2025;15:3117. PubMed Abstract available
SMITH CA, Paul S, Haney KE, Parra SG, et al A paper-based HPV E7 oncoprotein assay for cervical precancer detection at the
point of care.
Sci Rep. 2025;15:3041. PubMed Abstract available
PARK CH, Kim CW, Lee HW, Kwon MJ, et al Comparison of Liquid-Based Cytology EASYPREP and SurePath for Detection of
High-Risk HPV Genotypes.
Ann Clin Lab Sci. 2024;54:856-859. PubMed Abstract available
DONG W, Gao J, Mu Y, Wang Y, et al Effect of CXCR2 Deficiency in HeLa Cell on the Regulatory Network of Coding Genes
and Non-Coding RNAs.
Ann Clin Lab Sci. 2024;54:799-809. PubMed Abstract available
HHERA JJ, Dahaye R, Zakayo WE, Kazula YZ, et al Factors associated with cervical cancer screening among women of reproductive age
in Moshi municipality, Kilimanjaro, Tanzania: a cross-sectional study.
BMJ Open. 2025;15:e085223. PubMed Abstract available
ZHENG Q, He M, Mao Z, Huang Y, et al Advancing the Fight Against Cervical Cancer: The Promise of Therapeutic HPV
Vaccines.
Vaccines (Basel). 2025;13:92. PubMed Abstract available
KOCA T, Gocen Vardar N, Aksoy RA, Korcum AF, et al Comprehensive Evaluation of Inflammatory Biomarkers in Cervical Cancer Treated
with Chemoradiotherapy.
Curr Oncol. 2025;32:39. PubMed Abstract available
YANG T, Ji Z, Lei R, Qu A, et al Predicting High-Grade Acute Urinary Toxicity and Lower Gastrointestinal Toxicity
After Postoperative Volumetric Modulated Arc Therapy for Cervical and Endometrial
Cancer Using a Normal Tissue Complication Probability Model.
Curr Oncol. 2025;32:26. PubMed Abstract available
GUAN X, Yang R, Zhang J, Moon J, et al Programmable Multiplexed Nucleic Acid Detection by Harnessing Specificity Defect
of CRISPR-Cas12a.
Adv Sci (Weinh). 2025;12:e2411021. PubMed Abstract available
CAGNACCI A, Villa P, Grassi GP, Biglia N, et al Systemic hormone therapy after breast and gynecological cancers: an Italian
expert group consensus opinion.
Climacteric. 2025;28:4-14. PubMed Abstract available
PESUT E, Simic I, Kuzilkova D, Kalina T, et al Application of mass cytometry in multiparametric characterization of precancerous
cervical lesions.
Cytometry B Clin Cytom. 2025;108:55-66. PubMed Abstract available
BAEKER BISPO J, Lee H, Jemal A, Islami F, et al Associations of social support, living arrangements, and residential stability
with cancer screening in the United States.
Cancer Causes Control. 2025;36:157-169. PubMed Abstract available
CHEN R, Ding C, Wang D Association between folate level and cervical intraepithelial neoplasia risk: a
systematic review and meta-analysis.
Eur J Cancer Prev. 2025;34:185-192. PubMed Abstract available
MONTI E, Di Loreto E, Libutti G, Alberico D, et al Clinical significance of atypical glandular cells on cytology: 10 years'
experience of a colposcopic referral center.
Eur J Cancer Prev. 2025;34:106-112. PubMed Abstract available
TANG X, Zilla ML, Jiang W, He Y, et al The significance of extensive HPV genotyping for cervical high-grade neoplasia
among women with atypical glandular cells.
Am J Clin Pathol. 2025;163:134-142. PubMed Abstract available
SUN Y, Lin W, Zou Q, Zheng W, et al Gastric Type Endocervical Adenocarcinoma With Concurrent High-Grade Squamous
Intraepithelial Lesion: A Clinicopathologic Study of Three Patients.
Int J Surg Pathol. 2025;33:13-18. PubMed Abstract available
FOBIAN SF, Amin M, Sacchetti A, Seynhaeve ALB, et al Corrigendum to 'Investigating the delivery of PD-L1-targeted immunoliposomes in a
dynamic cervical cancer-on-a-chip model' [Journal of Controlled Release Volume
379, 10 March 2025, Pages 236-250].
J Control Release. 2025 Feb 6:S0168-3659(25)00099. PubMed
HASAN F, Timsaal Y, Gandhi TV, Shojaei H, et al Rare Gastric Metastasis From Cervical Cancer: A Case Report.
Clin Case Rep. 2025;13:e70181. PubMed Abstract available
ZAMMATARO L CINNAMON-GUI: Revolutionizing Pap Smear Analysis with CNN-Based Digital Pathology
Image Classification.
F1000Res. 2024;13:897. PubMed Abstract available
KAN X, Zhou Z, Liu L, Aiskikaer R, et al Significance of non-steroidal anti-inflammatory drugs in the prevention and
treatment of cervical cancer.
Heliyon. 2025;11:e42055. PubMed Abstract available
GUY MM, Bian T, Sun L, Hao Y, et al SLC7A11 is a potential therapeutic target and prognostic biomarker correlated
with immune cell infiltration in cervical cancer.
Discov Oncol. 2025;16:125. PubMed Abstract available
ZHOU Y, Zhang C, Wei H, Ding S, et al Directed evolution of proteoglycan-modifying enzymes: Functional applications in
cervical cancer therapy.
Int J Biol Macromol. 2025 Feb 4:140659. doi: 10.1016/j.ijbiomac.2025.140659. PubMed Abstract available
GUARIN-RIVERA S, Pineda-Arango H, Balaguera-Becerra C, Carreno-Jaimes M, et al Gemcitabine-induced digital necrosis in a patient with cervical squamous cell
carcinoma: case report and literature review.
Rev Colomb Obstet Ginecol. 2024;75. PubMed Abstract available
SHARMA N, Changotra H, Kaur M Molecular epidemiology of human papillomavirus variants in cervical cancer in
India.
Indian J Med Res. 2024;160:531-551. PubMed Abstract available
ROTH S, Lott B, Garo J, Allen J, et al Taking Health into Your Own Hands: Evaluating Patient and Provider Perspectives
of Human Papillomavirus Self-Sampling for Cervical Cancer Screenings and
Opportunities for Education.
J Cancer Educ. 2025 Feb 6. doi: 10.1007/s13187-025-02568. PubMed Abstract available
LI Y, Wang X, Li Y, Li W, et al The Combined Prognostic Value of (18)F-FDG PET/CT Metabolic Parameters of Immune
Organs and Hematological Immune-Related Markers in Patients With Locally Advanced
Cervical Cancer.
Cancer Med. 2025;14:e70650. PubMed Abstract available
LEON-GOMEZ P, Romero VI Human papillomavirus, vaginal microbiota and metagenomics: the interplay between
development and progression of cervical cancer.
Front Microbiol. 2025;15:1515258. PubMed Abstract available
RICCI C, Di Pumpo M, Nicolotti N, Capelli G, et al Major predictive factors for recurrence of CIN after treatment: an exploratory
analysis towards a predictive model.
Eur Rev Med Pharmacol Sci. 2025;29:23-29. PubMed Abstract available
BAHMANI B, Amini-Bayat Z, Ranjbar MM, Makoui MH, et al Development and evaluation of a novel E7 multi-epitopic vaccine for human
papillomavirus type 16: design, expression, purification, and immunological
characterization.
BMC Infect Dis. 2025;25:174. PubMed Abstract available
XIANG X, Tao X, Hua K, Jiang H, et al Single-cell RNA sequencing reveals tumor heterogeneity in small cell
neuroendocrine cervical carcinoma.
Commun Biol. 2025;8:184. PubMed Abstract available
OUYANG Y, Cao L, Zhao Q, Yang W, et al Biodegradable Mg-1%Ca alloy inhibits the growth of cervical cancer.
Biomed Mater. 2025 Feb 5. doi: 10.1088/1748. PubMed Abstract available
JONNALAGEDDA-CATTIN M, Moukam Datchoua AM, Yakam VF, Kenfack B, et al Barriers and Facilitators to the Preadoption of a Computer-Aided Diagnosis Tool
for Cervical Cancer: Qualitative Study on Health Care Providers' Perspectives in
Western Cameroon.
JMIR Cancer. 2025;11:e50124. PubMed Abstract available
KUERBANJIANG W, Peng S, Jiamaliding Y, Yi Y, et al Performance Evaluation of Large Language Models in Cervical Cancer Management
Based on a Standardized Questionnaire: Comparative Study.
J Med Internet Res. 2025;27:e63626. PubMed Abstract available
ZENG Z, Chen Y, Sun Y, Zhou B, et al Spectral computed tomography in the assessment of metastatic lymph nodes in
cervical cancer patients treated with definitive radiotherapy: a single-center,
prospective study.
Clin Exp Metastasis. 2025;42:15. PubMed Abstract available
WANG Y, Zhang W, Peng M E2F1-Dependent CDCA5 overexpression drives cervical cancer progression and
correlates with poor prognosis.
J Mol Histol. 2025;56:80. PubMed Abstract available
PAZ AA, Paula ACM, Lima AM, Castro GL, et al Health dashboard for information management in cervical cancer screening.
Rev Lat Am Enfermagem. 2025;33:e4446. PubMed Abstract available
DZOBO M, Dzinamarira T Effective cervical cancer prevention in sub-Saharan Africa needs the inclusion of
men as key stakeholders.
Front Oncol. 2025;15:1509685. PubMed
YOUNG AP, Olorunfemi M, Morrison L, Kelley SA, et al Cervical cancer screening: Impact of collection technique on human papillomavirus
detection and genotyping.
Prev Med Rep. 2025;50:102971. PubMed Abstract available
SAMARIA D, Tallutondok EB, Simanjorang C, Imanuel I, et al Comparison of Self-Efficacy and Knowledge of Human Papillomavirus Vaccination
among Various Types of Decision Makers in Indonesia: A Cross-Sectional Study.
Int J Community Based Nurs Midwifery. 2025;13:28-39. PubMed Abstract available
PURWAR R, Kanugonda J, Shukla M, Pandey M, et al An unusual case of post-menopausal bleeding.
World J Surg Oncol. 2025;23:37. PubMed Abstract available
QUILUMBA-DUTAN V, Carreon-Alvarez C, Sanabria-Ayala V, Hidalgo-Figueroa S, et al Assessment of Phage-Displayed Peptides Targeting Cancer Cell Surface Proteins: A
Comprehensive Molecular Docking Study.
J Pept Sci. 2025;31:e70004. PubMed Abstract available
HUANG CQ, Xiao WT, Yao XR, Li ZM, et al Elevated POSTN expression predicts poor prognosis and is associated with
radioresistance in cervical cancer patients treated with radical radiotherapy.
Sci Rep. 2025;15:4174. PubMed Abstract available
MARIAPPAN V, Kumararaja G, Subban R Folate-chitosan nanoparticles loaded with an apolar acetogenin inhibiting the
proliferation of cervical cancer cells.
Int J Biol Macromol. 2025;302:140640. PubMed Abstract available
FUJIWARA H, Takei Y, Saga Y, Jwa SC, et al Effectiveness of cervical cancer screening with cytology and human papillomavirus
co-testing: A 12-year retrospective study in Oyama district, Japan.
Cancer Epidemiol. 2025;95:102762. PubMed Abstract available
ZHANG L, Ma J, Zhang J, Hu M, et al Radiotherapy-Associated Cellular Senescence and EMT Alterations Contribute to
Distinct Disease Relapse Patterns in Locally Advanced Cervical Cancer.
Adv Sci (Weinh). 2025 Feb 4:e2412574. doi: 10.1002/advs.202412574. PubMed Abstract available
TORTELLI BA, Contreras J, Markovina S, Ding L, et al Characterization of the vaginal microbiome of postmenopausal patients receiving
chemoradiation for locally advanced cervical cancer.
JCI Insight. 2025 Feb 4:e176839. doi: 10.1172/jci.insight.176839. PubMed Abstract available
YOU Z, Lei Y, Yang Y, Zhou Z, et al Therapeutic target genes and regulatory networks of gallic acid in cervical
cancer.
Front Genet. 2025;15:1508869. PubMed Abstract available
GUO L, Liu Y, Zhang S, Liu W, et al Case report: Cutaneous metastasis of squamous cervical carcinoma: complete
regression after molecular diagnosis.
Front Immunol. 2025;15:1528957. PubMed Abstract available
ZHOU L, Li Y, Wang H, Qin R, et al Global cervical cancer elimination: quantifying the status, progress, and gaps.
BMC Med. 2025;23:67. PubMed Abstract available
HUANG Q, Yang W, Wang F, Huang R, et al SELP(+) TEC:CD8(+) T cell crosstalk associates with improved radiotherapy
efficacy in cervical cancer.
Mol Cancer. 2025;24:41. PubMed Abstract available
LEE SJ, Yoo JG, Kim JH, Park JY, et al Gynecologic oncology in 2024: breakthrough trials and evolving treatment
strategies for cervical, uterine corpus, and ovarian cancers.
J Gynecol Oncol. 2025;36:e72. PubMed Abstract available
YOO JG, Lee SJ, Nam EJ, No JH, et al Clinical practice guidelines for cervical cancer: an update of the Korean Society
of Gynecologic Oncology Guidelines.
J Gynecol Oncol. 2025;36:e70. PubMed Abstract available
FENG T, Zhang Y, Zheng G, Lv X, et al Efficacy and safety of cisplatin combined with paclitaxel concurrent radiotherapy
in patients with locally advanced cervical squamous cell carcinoma.
J Gynecol Oncol. 2025;36:e10. PubMed Abstract available
SHARIPOVA IP, Musabaev EI, Sadirova SS, Suyarkulova DT, et al Prevalence of high-risk human papillomavirus genotypes among women in Uzbekistan,
2021-2023.
J Gynecol Oncol. 2025;36:e7. PubMed Abstract available
GUO T, Zhao Y, Zeng J, Li J, et al Examined lymph node counts affected the staging and survival in cervical cancer:
a retrospective study using the SEER and Chinese cohort.
Ann Med. 2025;57:2459821. PubMed Abstract available
BABU MS, Kasting ML, Rodriguez NM Association between health insurance coverage and stage of diagnosis for cervical
cancer among females in Indiana from 2011 - 2019.
Prev Med Rep. 2025;50:102975. PubMed Abstract available
LI Y, Wu X Vaginal microbiome distinction in women with HPV+, cervical intraepithelial
neoplasia, and cervical cancer, a retrospective study.
Front Cell Infect Microbiol. 2025;14:1483544. PubMed Abstract available
SUN Y, Zhou Y, Peng Q, Zhou W, et al SERINC2-mediated serine metabolism promotes cervical cancer progression and
drives T cell exhaustion.
Int J Biol Sci. 2025;21:1361-1377. PubMed Abstract available
LU X, Zheng L, Jin X, Wang Y, et al Symptoms associated with concurrent chemoradiotherapy in patients with cervical
cancer: Application of latent profile analysis and network analysis.
Asia Pac J Oncol Nurs. 2024;12:100649. PubMed Abstract available
ULHE A, Raina P, Chaudhary A, Kaul-Ghanekar R, et al Alpha-linolenic acid-mediated epigenetic reprogramming of cervical cancer cell
lines.
Epigenetics. 2025;20:2451551. PubMed Abstract available
SALMAN L, Gien LT, Vicus D, Shier M, et al What Are the Current HPV Types Contributing to Cervical High Grade Squamous
Intraepithelial Lesion, Adenocarcinoma in Situ, and Early Cervical Cancer?
J Obstet Gynaecol Can. 2025 Jan 29:102783. doi: 10.1016/j.jogc.2025.102783. PubMed Abstract available
CHEN F, Xiong Y, Li S, Deng Y, et al Association between psychological flexibility and self-perceived burden in
patients with cervical cancer: A computer-simulated network analysis.
Eur J Oncol Nurs. 2025;74:102822. PubMed Abstract available
LU M, Hong X, Liu T, Mai B, et al Clinical characteristics and risk factors to high-grade vaginal intraepithelial
neoplasia: a single-institution study.
BMC Womens Health. 2025;25:44. PubMed Abstract available
CHEN X, Shi X, Zhang H, Pang H, et al Quality control study of cervical cancer interstitial brachytherapy treatment
plans using statistical process control.
Brachytherapy. 2025 Jan 31:S1538-4721(25)00005. PubMed Abstract available
DANG L, Mi M, Qiao Y, Zhu L, et al Eliminating cervical cancer in the Tibetan Plateau.
Lancet. 2025;405:375-376. PubMed
BI T, Wang Y, Qu W, Wang Y, et al A 10-year Retrospective Analysis on HPV Genotype Switching in a Tertiary Center
in China: Infection Characterization and Clinical Outcome.
J Med Virol. 2025;97:e70193. PubMed Abstract available
BECKHAUS T, Kachuri L, Nakase T, Schurmann P, et al Genome-Wide Association Analyses of HPV16 and HPV18 Seropositivity Identify
Susceptibility Loci for Cervical Cancer.
J Med Virol. 2025;97:e70195. PubMed Abstract available
KAUR H, Sharma R, Kaur J Comparison of deep transfer learning models for classification of cervical cancer
from pap smear images.
Sci Rep. 2025;15:3945. PubMed Abstract available
ISLAM SI, Ahmed SS, Mahfuj S, Das G, et al Investigating new drugs from marine seaweed metabolites for cervical cancer
therapy by molecular dynamic modeling approach.
Sci Rep. 2025;15:3866. PubMed Abstract available
STUEBS FA, Dietl AK, Schulmeyer CE, Behrens AS, et al Prognostic Significance of the Detection of Human Papilloma Virus L1 Protein in
Smears of Cervical Intraepithelial Neoplasia Grade 3 in Pregnant Women.
Anticancer Res. 2025;45:677-683. PubMed Abstract available
KAWUKI J, Savi V, Betunga B, Gopang M, et al Barriers to breast and cervical cancer screening among adolescent girls and young
women in Kenya: A nationwide cross-sectional survey.
Soc Sci Med. 2025;367:117722. PubMed Abstract available
NAVARRO CHICA CE, Alfonso Tobon LL, Lopez Abella JJ, Valencia Piedrahita MP, et al Nanoparticle-based colorimetric assays for early and rapid screening of the
oncogenic HPV variants 16 and 18.
Clin Chim Acta. 2025;568:120144. PubMed Abstract available
RIVERA-HERNANDEZ G, Sanchez ML, Rodriguez-Rodriguez J, Ramos-Parra PA, et al Bioactivity-guided identification of cytotoxic compounds from Tournefortia
hirsutissima L. by Fast Centrifugal Partition Chromatography.
J Ethnopharmacol. 2025;341:119301. PubMed Abstract available
MADSEN RR, Le Marois A, Mruk ON, Voliotis M, et al Oncogenic PIK3CA corrupts growth factor signaling specificity.
Mol Syst Biol. 2025;21:126-157. PubMed Abstract available
PARIC A, Tomic K, Alidzanovic L, Fojnica A, et al HPV-Related Cancers in Bosnia and Herzegovina: A Comprehensive Review.
Acta Med Acad. 2024;53:237-273. PubMed Abstract available
ZHU H, Guo X, Li X, Chang M, et al Clinical Effect Analysis and Prognostic Factors of Photodynamic Therapy for
Cervical Precancerous Lesions.
J Biophotonics. 2025;18:e202400454. PubMed Abstract available
OKAWA KS, Okawa S, Sasa H, Ishihara M, et al Clinical application of photoacoustic imaging for cervical precursor lesion
detection.
J Med Ultrason (2001). 2025;52:119-129. PubMed Abstract available
LIAO Z, Zou K, Lei M, Wu Y, et al Performance of Government-Financed Cervical Cancer Screening in Hunan, China and
Optimization of Triage Strategies.
J Low Genit Tract Dis. 2025 Feb 14. doi: 10.1097/LGT.0000000000000875. PubMed Abstract available
LI H, Xu Z, Liu C, Deng J, et al Probiotics: A New Approach for the Prevention and Treatment of Cervical Cancer.
Probiotics Antimicrob Proteins. 2025 Feb 14. doi: 10.1007/s12602-025-10479. PubMed Abstract available
LI Y, Liu A, Wang X, Guo L, et al The Role of Lymphocyte Recovery Index in Prognosis Prediction for Locally
Advanced Cervical Cancer With Radiation-Induced Lymphopenia.
Cancer Med. 2025;14:e70638. PubMed Abstract available
ZHENG Z, Chen Y, Wang C, Li L, et al Triptolide induces immunogenic cell death in cervical cancer cells via ER stress
and redox modulation.
Am J Cancer Res. 2025;15:69-83. PubMed Abstract available
CHEN Y, Liu S, Yin X Progress and prospects of the combination of BMI1-targeted therapy and
immunotherapy in cervical cancer.
Am J Cancer Res. 2025;15:217-232. PubMed Abstract available
ABUBAKARI AK, Gross J, Kwaku ID, Boateng IK, et al Factors Influencing Cervical Cancer Screening: A Cross-Sectional Study Among
Ethnically Diverse Women in the Kumasi Metropolis of Ghana.
Health Sci Rep. 2025;8:e70433. PubMed Abstract available
FUJISAWA K, Maeda H, Aida M, Kawanishi Y, et al [Two Cases of Splenic Tumors Safely Resected by Hand-Assisted Laparoscopic
Splenectomy].
Gan To Kagaku Ryoho. 2024;51:1684-1686. PubMed Abstract available
YUAN HB, Yu JH, Gan J, Qiu Y, et al Genetic variations and carcinogenicity analysis of E6/E7 oncogenes in HPV31 and
HPV35 in Taizhou, China.
Virol J. 2025;22:35. PubMed Abstract available
HAN C, Gao H, Li F, Lin L, et al TUFT1 Modulates Cell Proliferation, Migration, Invasion, Stemness and EGFR
Signaling in Cervical Cancer through Interacting with and Targeting ATF1.
Cell Biochem Biophys. 2025 Feb 13. doi: 10.1007/s12013-025-01673. PubMed Abstract available
ADIGUN MO, Esan DT, Oyinloye BE, Adeyanju BT, et al Knowledge and practice of health promotive lifestyle toward cervical cancer
prevention among women in Africa: A scoping review.
Cancer Treat Res Commun. 2025;43:100877. PubMed Abstract available
SRIHARIKRISHNAA S, Jishnu PV, Varghese VK, Shukla V, et al Identification of differentially expressed MiRNA clusters in cervical cancer.
Discov Oncol. 2025;16:172. PubMed Abstract available
SONG Z, Liu X, Jiang J, Yan X, et al Symptom clusters and self-management experiences of cervical cancer patients
undergoing concurrent chemoradiotherapy: a qualitative study.
Support Care Cancer. 2025;33:187. PubMed Abstract available
OLKOV IG, Grishina NK, Luzanov OA [The methodological approaches to evaluation of economical efficiency of
application of HPV-testing and cytological examination under provision of medical
care on "Obstetrics and Gynecology" profile].
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2025;33:48-52. PubMed Abstract available
XUE J, Wu M, Zhang J, Yang J, et al Delta-radiomics analysis based on magnetic resonance imaging to identify
radiation proctitis in patients with cervical cancer after radiotherapy.
Front Oncol. 2025;15:1523567. PubMed Abstract available
PALMGREN JE, Seppala J, Jaaskelainen E, Anttila M, et al The significance of free-hand needles in cervical cancer brachytherapy.
J Contemp Brachytherapy. 2024;16:443-448. PubMed Abstract available
WANG Y, Pang H, Lin S, Shi X, et al Early report on abbreviated brachytherapy schema for cervical cancer during the
COVID-19 pandemic.
J Contemp Brachytherapy. 2024;16:437-442. PubMed Abstract available
ZHANG J, Dong W, Yang Q, Liu LN, et al Dysregulation of G6PD by HPV E6 exacerbates cervical cancer by activating the
STAT3/PLOD2 pathway.
Carcinogenesis. 2025 Feb 13:bgaf005. doi: 10.1093. PubMed Abstract available
SAMBO T, Mathe E, Shai L, Mapfumari S, et al Inhibition of Kinase Activity and In Vitro Downregulation of the Protein Kinases
in Lung Cancer and Cervical Cancer Cell Lines and the Identified Known Anticancer
Compounds of Ziziphus mucronata.
Plants (Basel). 2025;14:395. PubMed Abstract available
YU K, Zhang S, Shen J, Yu M, et al Integrating Hypoxia Signatures from scRNA-seq and Bulk Transcriptomes for
Prognosis Prediction and Precision Therapy in Cervical Squamous Cell Carcinoma
and Endocervical Adenocarcinoma.
Int J Mol Sci. 2025;26:1362. PubMed Abstract available
LEE JH, Lim JY, Jeon YD, Kim DK, et al Methanol Extract of Pueraria lobata (Willd.) Root and Its Active Ingredient,
Puerarin, Induce Apoptosis in HeLa Cells and Attenuates Bacterial Vaginosis in
Gardnerella vaginalis-Infected Mice.
Int J Mol Sci. 2025;26:1342. PubMed Abstract available
HERRERA-QUITERIO GA, Valencia-Gonzalez HA, de la Cruz-Lopez KG, Fernandez-Coto DL, et al TMEM160 Promotes Tumor Growth in Lung Adenocarcinoma and Cervical Adenocarcinoma
Cell Lines.
Int J Mol Sci. 2025;26:1097. PubMed Abstract available
MING J, Cheng F, Fu Y, Zhang M, et al Long non-coding RNA H19 promotes cervical cancer development via targeting the
microRNA-140/ALDH1A1 axis.
Eur J Med Res. 2025;30:95. PubMed Abstract available
YANG C, Zou J, Luo X, Ou Y, et al Health inequality and improvement gap in the prevalence of gynecological cancers
among perimenopausal women globally, 1990-2019.
BMC Public Health. 2025;25:590. PubMed Abstract available
DAI Y, Li C, Cheng S, Wang H, et al Bioinformatics and experimental insights into F2RL1 as a key biomarker in
cervical cancer diagnosis and prognosis.
Sci Rep. 2025;15:5228. PubMed Abstract available
YAGI A, Ueda Y, Ikeda S, Oka E, et al A questionnaire survey of cervical and breast cancer screening among female
employees and employees' spouses.
Sci Rep. 2025;15:5277. PubMed Abstract available
GACHPAZAN M, Alashti AA, Jahantigh HR, Moghbeli M, et al Immunization with recombinant HPV16-E7d in fusion with Flagellin as a cancer
vaccine: Effect of antigen-adjuvant orientation on the immune response pattern.
Immunol Res. 2025;73:50. PubMed Abstract available
TRYBUS W, Trybus E, Obarzanowski M, Krol T, et al Quinalizarin induces autophagy, apoptosis and mitotic catastrophe in cervical and
prostate cancer cells.
Sci Rep. 2025;15:5252. PubMed Abstract available
YANG Y, Zhou H, Wang YK, Dai Y, et al [Construction and preliminary validation of machine learning predictive models
for cervical cancer screening based on human DNA methylation].
Zhonghua Zhong Liu Za Zhi. 2025;47:193-200. PubMed Abstract available
ZHU Y, Cheng H, Xu M, Li G, et al Curcuma Aeruginosa Roxb. [C.zedoaria non Rosc.] Inhibits Human
Papillomavirus-Related Cervical Cancer via Dipeptidyl Peptidase IV.
Tohoku J Exp Med. 2025 Feb 13. doi: 10.1620/tjem.2025. PubMed
GONG W, Wang Z, Wei Y, Wang M, et al Dynamic changes in peripheral blood immunophenotyping and its prognostic value in
cervical cancer patients undergoing immune checkpoint blockade therapy.
Discov Oncol. 2025;16:167. PubMed Abstract available
ZOU W, Lou J, Yi Y, Cui Y, et al Andrographolide suppresses cervical cancer progression by targeting angiogenesis
and inducing apoptosis in a CAM-PDX model.
Biomol Biomed. 2025 Feb 11. doi: 10.17305/bb.2025.11432. PubMed Abstract available
SONI S, Amin S, Pundhir A, Ramotra RK, et al Assessment of 5A's of Human Papilloma Virus Vaccination: Awareness, Attitude,
Apprehension, Action Expected and Acceptability Amongst Health Care Providers,
Medical Students, Para-Medical and Administration Staff in AIIMS Rajkot.
J Med Virol. 2025;97:e70231. PubMed Abstract available
HENDRICKX JO, Van Keer S, Donders G, Weyers S, et al Home-based urinary HPV self-sampling for the detection of cervical cancer
precursor lesions: attitudes and preferences from Belgian females participating
in the CASUS study.
Arch Public Health. 2025;83:32. PubMed Abstract available
MOHAMED AMIN S, Metwally El-Sayed M, Hashem El-Monshed A, Hussein Ramadan Atta M, et al Unlocking prevention: the role of health literacy in cervical cancer screening:
community nursing perspective.
BMC Nurs. 2025;24:160. PubMed Abstract available
PAN F, van der Schans J, Nazrul N, Koot JAR, et al The effect of hrHPV prevalence on cervical cancer screening strategies: a
cost-effectiveness study of Bangladesh.
BMC Public Health. 2025;25:561. PubMed Abstract available
AMBIKILE JS, Msengi EA, Chona EZ, Gosse RA, et al Coping strategies utilized by patients with cervical cancer: an explorative
qualitative study at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania.
BMC Womens Health. 2025;25:59. PubMed Abstract available
WEI A, Tang X ASO Author Reflections: How to Individually and Precisely Reduce the Surgical
Scope for Cervical Cancer Patients to Decrease the Incidence of Postoperative
Complications.
Ann Surg Oncol. 2025 Feb 11. doi: 10.1245/s10434-025-16966. PubMed
WANG X, Ju Z, Lai Q, Liu Q, et al Analysis of human papillomavirus infection and its correlation with cervical
lesions in Huizhou women.
Sci Rep. 2025;15:5115. PubMed Abstract available
PAUL S, Patra D, Kundu R Author Correction: Lignan enriched fraction (LRF) of Phyllanthus amarus promotes
apoptotic cell death in human cervical cancer cells in vitro.
Sci Rep. 2025;15:5131. PubMed
NIGUDGI A, Tiwari P, Chandel HS, Singh P, et al "High incidence of abnormal pap smears and low awareness of cervical cancer among
women in Rewa, Madhya Pradesh, India: Implications for screening and education".
Cancer Epidemiol. 2025;95:102767. PubMed Abstract available
NATUHWERA G, Ellis P The Impact of Chronic Pelvic Pain and Bowel Morbidity on Quality of Life in
Cervical Cancer Patients Treated With Radio (Chemo) Therapy. A Systematic
Literature Review.
J Pain Res. 2025;18:597-618. PubMed Abstract available
JI S, Ji N Methylation sites of human papillomavirus 16 as potential biomarkers for cervical
cancer progression.
Front Oncol. 2025;15:1481621. PubMed Abstract available
SHI J, Chen J, He G, Peng Q, et al Artificial intelligence in high-dose-rate brachytherapy treatment planning for
cervical cancer: a review.
Front Oncol. 2025;15:1507592. PubMed Abstract available
DONG B, Lu Z, Yang T, Wang J, et al Development, validation, and clinical application of a machine learning model for
risk stratification and management of cervical cancer screening based on
full-genotyping hrHPV test (SMART-HPV): a modelling study.
Lancet Reg Health West Pac. 2025;55:101480. PubMed Abstract available
KWON YS, Weerasinghe HA, Yen A, Medrano A, et al The Utility of a Y-tandem Applicator in a Patient With Stage IVA Locally Advanced
Cervical Cancer in the Setting of a Bicornuate Uterus.
Cureus. 2025;17:e77151. PubMed Abstract available
HE Y, Ge J, Zhao S, Zhou F, et al METTL3-mediated NFAT5 Upregulation Promotes Cervical Cancer Progression Through
Enhancing the Mitochondrial Function by Transcriptional Regulation of PRDX1.
J Biochem Mol Toxicol. 2025;39:e70162. PubMed Abstract available
GIL-IBANEZ B, Carreras-Dieguez N, Lopez G, Sanchez-Hoyo B, et al A multimodal intervention program to improve sexual health and self-perceived
quality of life in patients treated for cervical cancer: a randomized prospective
study (PROVIDENCE trial).
J Gynecol Oncol. 2025 Jan 29. doi: 10.3802/jgo.2025. PubMed Abstract available
MIN L, Huo F, Zhu Z, Din L, et al Mechanistic study of METTL3 inducing ferroptosis to promote cervical cancer
progression through mediating m6A modification of COTE-1.
Cell Signal. 2025;128:111649. PubMed Abstract available
DOMGUE JF, Chandra M, Yu R, Shete S, et al Adherence to cervical cancer screening among sexual and racial/ethnic minorities
during the covid-19 pandemic in the United States.
Am J Obstet Gynecol. 2025 Feb 7:S0002-9378(25)00088. PubMed
POUDEL S, Rai S, Adhikari SP, Dhakal S, et al Knowledge and Attitude Towards Human Papilloma Virus and Human Papilloma Virus
Vaccine.
J Nepal Health Res Counc. 2024;22:622-626. PubMed Abstract available
SHI R, Zhao C Stability, Hopf bifurcation and control of a fractional order delay cervical
cancer model with HPV infection.
Comput Methods Biomech Biomed Engin. 2025. PubMed Abstract available
LIU X, Wang Y, Gao B, Lu X, et al Modeling optimal combination of breast and cervical cancer screening strategies
in China.
BMC Womens Health. 2025;25:56. PubMed Abstract available
MARTIN-QUESADA AI, Perez-Mendez L, Perez-Rodriguez ND Evaluating the benefits of immunotherapy in metastatic cervical cancer: an
observational retrospective analysis.
Clin Transl Oncol. 2025 Feb 8. doi: 10.1007/s12094-025-03852. PubMed Abstract available
OLA IO, Okunowo AA, Habeebu MY Mortality risk stratification based on comorbidity status among cervical cancer
patients in Lagos, Nigeria.
Int Health. 2025 Feb 8:ihaf008. doi: 10.1093. PubMed Abstract available
CAO X, Pan X, Ren Z, Gong P, et al Cryptotanshinone Inhibits Obesity-Related Cervical Cancer by Down-Regulating
CXCL8 Expression in Hela Cells.
Chem Biodivers. 2025 Feb 7:e202403263. doi: 10.1002/cbdv.202403263. PubMed Abstract available
WANG J, Ma S, Ge K, Yao Y, et al Dual-OR Logic-Gated Lateral Flow Strip Assay Based on Colorimetric-Fluorescence
Dual Indication for Screening of HPV16/18 in Multiple Scenarios.
Anal Chem. 2025;97:2963-2971. PubMed Abstract available
LEE H, Bauleni E, Maluwa V, Lee S, et al Health behavior and social crisis in the era of COVID-19 in Malawi: A
decolonizing approach to a qualitative study.
Nurs Outlook. 2025;73:102317. PubMed Abstract available
LI W, Zhang C, Gao T, Sun Y, et al Human umbilical cord mesenchymal stem cells small extracellular vesicles-derived
miR-370-3p inhibits cervical precancerous lesions by targeting DHCR24.
Stem Cells Transl Med. 2025;14:szae087. PubMed Abstract available
RANA SK, Perkins RB, Carr D, Feldman S, et al Evaluation of Human Papillomavirus Vaccination and Cancer Prevention Behaviors
among LGBTQI + Individuals: A Cross-Sectional Study.
J Community Health. 2025;50:98-110. PubMed Abstract available
MIYAMOTO T, Ida K, Tanaka Y, Asaka S, et al Whole-exome Sequence Analysis of Gastric-type Adenocarcinoma of the Uterine
Cervix and Adjacent Lobular Endocervical Glandular Hyperplasia in the Same Case.
Int J Gynecol Pathol. 2025;44:125-129. PubMed Abstract available
PEDROSO CM, do Santos ES, Alves FA, Martins MD, et al Surgical protocols for oral leukoplakia and precancerous lesions across three
different anatomic sites.
Oral Dis. 2025;31:89-98. PubMed Abstract available
ADZIGBLI LA, Aboagye RG, Adeleye K, Osborne A, et al Cervical cancer screening uptake and its predictors among women aged 30-49 in
Ghana: Providing evidence to support the World Health Organization's cervical
cancer elimination initiative.
BMC Infect Dis. 2025;25:246. PubMed Abstract available
AHMED SR, Befano B, Egemen D, Rodriguez AC, et al Generalizable deep neural networks for image quality classification of cervical
images.
Sci Rep. 2025;15:6312. PubMed Abstract available
YANG J, Zhang Y, Fan W, Wang J, et al A novel lightweight multi-scale feature fusion segmentation algorithm for
real-time cervical lesion screening.
Sci Rep. 2025;15:6343. PubMed Abstract available
LI ZY, Wang K, Shen XL, Li Q, et al Factors associated with CIN2-3 recurrence: A single center retrospective
analysis.
Hum Vaccin Immunother. 2025;21:2469410. PubMed Abstract available
GOSECKA M, Jaworska-Krych D, Gosecki M, Urbaniak M, et al Construction of Dynamic Hydrogel Inducing Effective and Selective 5-Fluorouracil
Monotherapy against Cervical Cancer Cells.
ACS Appl Mater Interfaces. 2025 Feb 21. doi: 10.1021/acsami.4c20276. PubMed Abstract available
WENTZENSEN N, Massad LS, Clarke MA, Garcia F, et al Self-Collected Vaginal Specimens for HPV Testing: Recommendations From the
Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee.
J Low Genit Tract Dis. 2025 Feb 21. doi: 10.1097/LGT.0000000000000885. PubMed Abstract available
VAN KEER S, Teblick L, Donders G, Weyers S, et al Clinical and Analytical Evaluation of the Abbott Alinity m HR HPV Assay in a New
Generation First-Void Urine Collector.
J Med Virol. 2025;97:e70254. PubMed Abstract available
GYLLENSTEN U Novel diagnostics for improved treatment of gynecological cancer.
Ups J Med Sci. 2025;130. PubMed Abstract available
SHAHRAKI HR Comments on "The mRNA and Protein Levels of the Glycolytic Enzymes Lactate
Dehydrogenase A (LDHA) and Phosphofructokinase Platelet (PFKP) Are Good
Predictors of Survival Time, Recurrence, and Risk of Death in Cervical Cancer
Patients".
Cancer Med. 2025;14:e70691. PubMed
GOPALKRISHNAN K, Karim R Addressing Global Disparities in Cervical Cancer Burden: A Narrative Review of
Emerging Strategies.
Curr HIV/AIDS Rep. 2025;22:18. PubMed Abstract available
LEON-MALDONADO LS, Lopez-Olmedo N, Murillo R, Hurtado-Salgado E, et al [Not Available].
Salud Publica Mex. 2024;66. PubMed Abstract available
ZHU Y, Xu W, He Y, Yang W, et al Therapeutic implications of endoplasmic reticulum stress gene CCL3 in cervical
squamous cell carcinoma.
Cell Biol Toxicol. 2025;41:47. PubMed Abstract available
HE Y, Ni H, Kuang W, Fu L, et al Advances in HPV-Associated Cervical Cancer Dynamic Modelling for Prevention and
Control Evaluation.
China CDC Wkly. 2025;7:225-229. PubMed Abstract available
LIU X, Li W, Yang C, Luo J, et al Cuproptosis-related genes signature could predict prognosis and the response of
immunotherapy in cervical cancer.
Transl Cancer Res. 2025;14:129-140. PubMed Abstract available
HOU Y, Zhang L, Li H, Zhang R, et al Exploration of key pathogenic mechanisms and potential intervention targets of
the traditional Chinese medicine Coptis chinensis in the treatment of cervical
cancer based on network pharmacology and molecular docking techniques.
Transl Cancer Res. 2025;14:626-639. PubMed Abstract available
WANG Y, Yao J, Wei M, Jiang Q, et al EPB41L4A-AS1 regulates cervical cancer by proliferative cells: mendelian
randomization and single-cell transcriptomics analyses.
Transl Cancer Res. 2025;14:354-370. PubMed Abstract available
KLAT J, Romanova M, Zidlik V, Simetka O, et al L1CAM is not prognostic factor in HPV-associated adenocarcinoma and adenosquamous
cell carcinoma of the uterine cervix.
Cancer Biomark. 2024;41:CBM240101. PubMed Abstract available
LAI YK, Ye JF, Zhao X How face-to-face and online patient-provider communication associate with
cervical cancer screening behaviors: The mediating roles of HPV awareness and
cancer worry.
J Health Psychol. 2025 Feb 19:13591053251316502. doi: 10.1177/13591053251316502. PubMed Abstract available
SONG J, Wang J Cervical cancer screening: comparative study of human papillomavirus detection
between cervical cytology and urine samples.
BMC Womens Health. 2025;25:71. PubMed Abstract available
YAO S, Sun L, Lu Y, Zhu X, et al Eliminating VEGFA+ tumor-associated neutrophils by antibody-drug conjugates
boosts antitumor immunity and potentiates PD-1 immunotherapy in preclinical
models of cervical cancer.
Cell Death Dis. 2025;16:115. PubMed Abstract available
BOSE S, Mandal R, Banerjee D, Vernekar M, et al Analysis of time trends of prevalence of high-risk HPV infections, high grade
cervical precancer and cervical cancer disease in women from Eastern India over
20 years - Pooled analysis from three studies.
Cancer Epidemiol. 2025;95:102776. PubMed Abstract available
NADYROVA AI, Petrushanko IY, Mitkevich VA, Ilinskaya ON, et al [Redox Status and Protein Glutathionylation in Binase-Treated HPV16-Positive SiHa
Carcinoma Cells].
Mol Biol (Mosk). 2024;58:811-820. PubMed Abstract available
DELGADO LOPEZ D, Acosta Bedon A, Rivas-Parraga R, Heredia M, et al Assessing the Acceptability of a Vaginal Self-Sampling Device in a Rural Parish
of Cuenca, Ecuador.
J Prim Care Community Health. 2025;16:21501319251320172. PubMed Abstract available
YANG J, Chen S, Liu Y, Wang P, et al Identification of a novel hypermethylation marker, ZSCAN18, and construction of a
diagnostic model in cervical cancer.
Clin Transl Oncol. 2025 Feb 19. doi: 10.1007/s12094-025-03864. PubMed Abstract available
ANDRADE RLF, Ramos APAS, Queiroz FR, Melo Neto AB, et al Validation of cervical cancer genetic signature in minimally invasive samples.
An Acad Bras Cienc. 2025;97:e20240824. PubMed Abstract available
MOHAMED AO, Long R, He Y, Wang X, et al Comprehensive Analysis of Clinical and Molecular Features in Cancer Patients
Associated With Major Human Oncoviruses.
J Med Virol. 2025;97:e70239. PubMed Abstract available
DING Y, Wang C, Shu Y, Wang J, et al Cost-effectiveness analysis of a first-line treatment with cadonilimab plus
platinum-based chemotherapy with or without bevacizumab for persistent,
recurrent, or metastatic cervical cancer in China: COMPASSION-16 trial.
J Pharm Policy Pract. 2025;18:2464781. PubMed Abstract available
NA J, Li Y, Lu Q, Wang Y, et al Investigating the impact of persistent HPV infection on recurrence of lesions
post-surgery for early-stage cervical cancer and related influencing factors.
Front Oncol. 2025;15:1506521. PubMed Abstract available
XIA SJ, Zhao B, Li Y, Kong X, et al Cer-ConvN3Unet: an end-to-end multi-parametric MRI-based pipeline for automated
detection and segmentation of cervical cancer.
Eur Radiol Exp. 2025;9:20. PubMed Abstract available
PENG YS, Tian N, Feng XL, Zhang R, et al [The expression of YTHDF2 in cervical lesions and its relationship with prognosis
based on bioinformatics].
Zhonghua Liu Xing Bing Xue Za Zhi. 2025;46:280-287. PubMed Abstract available
DEATERLY CD, Forsyth B, Nazario P, Bhagwat S, et al Impacts of Substance Use and Mental Health Symptoms on Cervical Cancer Screening
and Viral Suppression: A Mixed Methods Study With Reproductive-Age Women With HIV
in Florida.
J Assoc Nurses AIDS Care. 2025 Feb 18. doi: 10.1097/JNC.0000000000000529. PubMed Abstract available
LIU SQ, Cheng XX, He S, Xia T, et al Super-enhancer-driven EFNA1 fuels tumor progression in cervical cancer via the
FOSL2-Src/AKT/STAT3 axis.
J Clin Invest. 2025 Feb 18:e177599. doi: 10.1172/JCI177599. PubMed Abstract available
MIN S, Li Q, Li Z, Huang H, et al Association of CDK8 Gene Polymorphisms with Cervical Cancer in Han Women in
Southwest China.
Genet Test Mol Biomarkers. 2025;29:39-47. PubMed Abstract available
LU Z, Dong B, Yao P, Huang Y, et al Characteristics of Human Papillomavirus Prevalence and Infection Patterns Among
Women Aged 35-65 in Fujian Province, China: A Nine-Year Retrospective
Observational Study.
J Med Virol. 2025;97:e70238. PubMed Abstract available
GEZIMU W, Demeke A, Bekele F, Alemu SS, et al Overview of female healthcare providers' outlooks on cervical cancer screening: a
narrative review.
Front Oncol. 2025;15:1496513. PubMed Abstract available
MA X, Wu C, Wu T, Yu X, et al Genotypic analysis of human papillomavirus in cervical exfoliated cells from
women in Zigong.
Virol J. 2025;22:40. PubMed Abstract available
VAGHASIA H, Patel R, Prajapati J, Shah K, et al Cytotoxic and immunomodulatory properties of Tinospora cordifolia, Boerhaavia
diffusa, Berberis aristata, and Ocimum basilicum extracts against HPV-positive
cervical cancer cell line.
BMC Complement Med Ther. 2025;25:59. PubMed Abstract available
GUO M, He M, Dang Y, Lei L, et al Predictors of para-aortic lymph node metastasis based on pathological diagnosis
via surgical staging in patients with locally advanced cervical cancer: A
multicenter study.
Cancer Lett. 2025 Feb 15:217545. doi: 10.1016/j.canlet.2025.217545. PubMed Abstract available
RATH S, Oommen AM, Cherian AG Screening for cervical and breast cancer among community health care workers
(ASHAs) of Puri district, Odisha.
Indian J Cancer. 2024;61:805-811. PubMed Abstract available
KALAVATHY MC, Mathew A, Krishna KMJ, Saritha VN, et al High-risk human papillomavirus infection among women with atypical squamous cells
of undetermined significance in Pap smear: A seven-year follow-up study in South
India.
Indian J Cancer. 2024;61:797-804. PubMed Abstract available
RETRACTION: Development of Gene Panel for Predicting Recurrence in Early-Stage
Cervical Cancer Patients.
Environ Toxicol. 2025 Feb 17. doi: 10.1002/tox.24495. PubMed Abstract available
KIM SH, Lee DS Orostachys japonicus induce caspase-dependent apoptosis in HeLa human cervical
cancer cells.
Nutr Res Pract. 2025;19:131-142. PubMed Abstract available
SUN X, He L, Wang S Risk factors for pelvic lymph node metastasis in cervical cancer: a retrospective
analysis of 186 patients.
Front Oncol. 2025;15:1525946. PubMed Abstract available
LI F, Ma Q, Jiang M, Jiang J, et al Clinical value of miR-216a-5p and miR-34a in early screening for cervical cancer.
Am J Transl Res. 2025;17:462-470. PubMed Abstract available
GONG L, Xiao Q, Xie X, Zheng Q, et al Correlation analysis on risk factors for cervical cancer in perimenopausal women.
Am J Transl Res. 2025;17:211-220. PubMed Abstract available
LI DL, Li W, Chen ZJ Enhanced recovery after surgery in the perioperative period promotes recovery of
cervical cancer patients undergoing transabdominal radical resection.
Am J Transl Res. 2025;17:230-238. PubMed Abstract available
HUANG X, Ruan G, Sun P Assessment of Knowledge Gaps in Cervical Cancer Screening and HPV Vaccination
Among Chinese Women: A Comprehensive Population-Based Study.
Cancer Manag Res. 2025;17:267-279. PubMed Abstract available
RETRACTION: USP14 Promotes the Proliferation of Cervical Cancer via Upregulating
beta-Catenin.
Environ Toxicol. 2025 Feb 17. doi: 10.1002/tox.24493. PubMed Abstract available
WISEMAN J, Patterson K, Kliewer G, Mueller M, et al Integrated access to cancer screening: expanding access for cervical and
colorectal cancer screening in rural and remote Northern Alberta, Canada using a
mobile service to bring cancer screening closer to home.
BMC Health Serv Res. 2025;25:260. PubMed Abstract available
LI X, Yang X, Lin S, Cong H, et al Perineural Invasion in Cervical Cancer.
Cancer Lett. 2025 Feb 14:217561. doi: 10.1016/j.canlet.2025.217561. PubMed Abstract available
FOGARASI IA, Melczer Z, Gyulai A [Emerging role of primary care health visitors in population-based cervical
screening].
Orv Hetil. 2025;166:263-271. PubMed
WEN Q, Wang S, Min Y, Liu X, et al Associations of the gut, cervical, and vaginal microbiota with cervical cancer: a
systematic review and meta-analysis.
BMC Womens Health. 2025;25:65. PubMed Abstract available
BUTLER S, Niedermayr T, Kidd EA 3D-printed needle guides for cervical cancer brachytherapy: Optimized dosimetry
and improved local control outcomes.
Brachytherapy. 2025 Feb 14:S1538-4721(25)00010. PubMed Abstract available
CUI Y, Zhou W, Zhang B, Li F, et al Application of Early Dynamic (18)F-FDG PET/CT in T1 and T2 Cervical Cancer.
Clin Radiol. 2025;83:106816. PubMed Abstract available
SOLTANIZADEH S, Bjorn SF, Froding LP, Mosgaard BJ, et al Oncological outcomes after vaginal and robotic-assisted radical trachelectomy in
patients with cervical cancer - A single-center prospective cohort study.
Eur J Surg Oncol. 2025;51:109671. PubMed Abstract available
VARON ML, Salcedo MP, Fellman B, Troisi C, et al Addressing the cervical cancer burden in the Rio Grande Valley of Texas through a
multi-component program to improve screening and diagnostic follow-up: A
retrospective cohort study.
Cancer Epidemiol. 2025;95:102772. PubMed Abstract available
LI Y, Lu R, Abuduhailili X, Feng Y, et al NSUN7 promotes cervical cancer progression through activation of ErbB signaling
pathway.
Funct Integr Genomics. 2025;25:37. PubMed Abstract available
HAIYE J, Xiangzhu W, Yunfei Z, Shumin G, et al Overexpressed NEK2 contributes to progression and cisplatin resistance through
activating the Wnt/beta-catenin signaling pathway in cervical cancer.
Cancer Cell Int. 2025;25:45. PubMed Abstract available
IKPEAMA CR, Edjekpewhu CLJ Knowledge of Cervical Cancer Among Women of Childbearing Age: A Qualitative Study
of a Local Council in South-Eastern Nigeria.
Soc Work Public Health. 2025 Feb 14:1-16. doi: 10.1080/19371918.2025.2467399. PubMed Abstract available
EVANS M, Liu KJ, Rego A, Ogbonna N, et al "It's a low-key thing of eugenics": Disability reproductive injustice in barriers
to cervical cancer screening during the COVID-19 pandemic.
Soc Sci Med. 2025;369:117807. PubMed Abstract available
ZHANG Y, Liu Y, Deng Q, Liu L, et al USP43 drives cervical carcinoma progression through regulation of the Hippo/TAZ
pathway.
Int Immunopharmacol. 2025;149:114217. PubMed Abstract available
TANG R, Yao Q, Zhang K, Yu Q, et al Revolutionizing prognosis: Introducing cell death index (CDI) as a powerful
prognostic tool for CSCC patients.
Environ Toxicol. 2025;40:481-492. PubMed Abstract available
SHERIDAN B, Irzaldy A, Heijnsdijk EAM, Dimitrova N, et al Prioritizing performance and outcome indicators for quality assessment of cancer
screening programs in the EU.
Public Health. 2025;239:185-192. PubMed Abstract available
MADATHIL S, Dhouib M, Lelong Q, Bourassine A, et al A multimodal deep learning model for cervical pre-cancers and cancers prediction:
Development and internal validation study.
Comput Biol Med. 2025;186:109710. PubMed Abstract available
PARKER VL, Long E, Ellis K, Macdonald MC, et al Predictors for negative large loop excision of the transformation zone (LLETZ) in
a primary HPV screened population.
J Gynecol Obstet Hum Reprod. 2025;54:102913. PubMed Abstract available
RUIZ JI, Radabaugh C, Geng Y, Suarez-Almazor ME, et al Content and quality of consumer websites providing information about human
papillomavirus infection in patients with systemic lupus erythematosus: An
environmental scan.
Patient Educ Couns. 2025;133:108644. PubMed Abstract available
DESAI KT, Ajenifuja KO, Adepiti CA, Inturrisi F, et al Validation of a simplified HPV genotyping assay designed for cervical screening
in low-resource settings.
J Clin Microbiol. 2024 Dec 31:e0163924. doi: 10.1128/jcm.01639. PubMed Abstract available
ZHANG Y, Chen R, Zhou Z, Qing W, et al Ureaplasma parvum serovar 6 may be a novel element in the progression of HPV
infection to CIN: A cross-sectional study of 7058 women.
J Infect. 2025;90:106397. PubMed Abstract available
GODDARD KAB, Feuer EJ, Mandelblatt JS, Meza R, et al Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment
Efforts, 1975-2020.
JAMA Oncol. 2025;11:162-167. PubMed Abstract available
SOKALE IO, Kuo DC, Hoppenot CM, Reitzel LR, et al Self-Collection for Primary HPV Testing: Acceptability in a Large Urban Emergency
Department.
Ann Emerg Med. 2025;85:249-257. PubMed Abstract available
SASO S, Barcroft JF, Kasaven LS, Galazis N, et al An umbrella review of meta-analyses regarding the incidence of female-specific
malignancies after fertility treatment.
Fertil Steril. 2025;123:506-519. PubMed Abstract available
MOHAREB RM, Abdelaziz MA, Jame R, Omer N, et al Synthesis of New Chromen-5-one Derivatives from Dimedone and their
Antiproliferative Evaluations against Selected Cancer Cell Lines Together with
Hepatocellular Carcinoma and Cervical Carcinoma.
Anticancer Agents Med Chem. 2025;25:134-149. PubMed Abstract available
GOUNTAS I, Aman M, Alexander D, Hughes R, et al Estimating the time required to reach HPV vaccination targets across Europe.
Expert Rev Vaccines. 2025;24:165-172. PubMed Abstract available
LOVANE L, Carrilho C, Karlsson C Tissue microarray validation in cervical carcinoma studies. A methodological
approach.
Histol Histopathol. 2025;40:317-325. PubMed Abstract available
GUSTAFSON LW, Krog L, Sardini B, Tranberg M, et al High rate of persistent HPV detection after diagnostic cervical excision in older
screen-positive women.
Acta Obstet Gynecol Scand. 2025;104:342-349. PubMed Abstract available
LIN LH, Kaur H, Kolin DL, Nucci MR, et al Claudin-18 and Mutation Surrogate Immunohistochemistry in Gastric-type
Endocervical Lesions and their Differential Diagnoses.
Am J Surg Pathol. 2025;49:206-216. PubMed Abstract available
PENNINX BMF, Samson MJ, Schnog JB Pembrolizumab with chemoradiotherapy followed by pembrolizumab for stage III-IVa
cervical cancer: is the ENGOT-cx11/GOG-3047/KEYNOTE-A18 trial practice changing?
Cancer. 2025;131:e35749. PubMed Abstract available
DUSKA LR, Petroni GR, Thaker PH, Crane EK, et al Update on safety and feasibility of the combination of pembrolizumab and pelvic
chemoradiation in locally advanced cervical cancer.
Cancer. 2025;131:e35757. PubMed Abstract available
NIERENGARTEN MB New standard of care for patients with locally advanced cervical cancer.
Cancer. 2025;131:e35739. PubMed
YANG Y, Xian D, Yu L, Kong Y, et al Integration of AI-Assisted in Digital Cervical Cytology Training: A Comparative
Study.
Cytopathology. 2025;36:156-164. PubMed Abstract available
ELEUTERIO JUNIOR J, Eleuterio RMN Contaminant Suggesting Rotifer in Liquid-Based Cytology of the Cervix.
Diagn Cytopathol. 2025;53:136-138. PubMed Abstract available
KIM YJ, Lee J, Park S, Kim YM, et al The value of magnetic resonance imaging in predicting vesicovaginal fistula in
cervical cancer with bladder invasion treated with definitive chemoradiotherapy.
Gynecol Oncol. 2025;193:136-140. PubMed Abstract available
NGUYEN T, Yi Y, Morron S, Brittain D, et al Living in a food desert in Louisiana and its effects on gynecologic cancer
outcomes.
Gynecol Oncol. 2024;192:137-144. PubMed Abstract available
MACDUFFIE E, Kernell C, George J, Bvochora-Nsingo M, et al Efficacy of induction chemotherapy during the COVID-19 pandemic for treatment of
locally advanced cervical cancer in Botswana.
Gynecol Oncol. 2025;194:91-97. PubMed Abstract available
DU L, Sun H, Tang L, Hao S, et al Cervical cancer incidence rates considering migration status in mainland China
using Bayesian model-Estimation based on 2016 cancer registry data.
Int J Cancer. 2025 Jan 23. doi: 10.1002/ijc.35346. PubMed Abstract available
PEDERSEN BT, Sonne SB, Pedersen H, Andreasen EK, et al Participation and relative cost of attendance by direct-mail compared to opt-in
invitation strategy for HPV self-sampling targeting cervical screening
non-attenders: A large-scale, randomized, pragmatic study.
Int J Cancer. 2024 Nov 23. doi: 10.1002/ijc.35263. PubMed Abstract available
SAHLI L, Siegenthaler F, Buchi CA, Hofer S, et al Role of pre-sacral sentinel lymph nodes in endometrium and cervical cancer:
experience with minimally invasive indocyanine green sentinel lymph node mapping.
Int J Gynecol Cancer. 2025;35:100032. PubMed Abstract available
MORICE P, Gouy S Correspondence on "Fertility-sparing treatment with conization versus radical
hysterectomy in patients with early-stage cervical cancer: inverse propensity
score weighted analysis," by Ditto et al.
Int J Gynecol Cancer. 2025;35:100028. PubMed
AFROZE L, Rahman MS Men's role in women's health: Engaging male partners in cervical cancer
prevention efforts in low-to-middle-income countries.
Int J Gynecol Cancer. 2025;35:100021. PubMed
PRETI M, Lewis F, Carcopino X, Bevilacqua F, et al Vulvar inspection at the time of cervical cancer screening: European Society of
Gynaecological Oncology (ESGO), International Society for the Study of
Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease
(ECSVD), and European
Int J Gynecol Cancer. 2025;35:100007. PubMed Abstract available
RAMIREZ PT Minimally invasive surgery for simple hysterectomy in early-stage cervical
cancer: 'SHAPing' a path forward.
Int J Gynecol Cancer. 2025;35:101619. PubMed
ANAKWENZE C, Kalra A, Lumley C, Chinniah G, et al Cervical cancer stage distribution and survival outcomes in Africa: a systematic
review and meta-analysis.
Int J Gynecol Cancer. 2025;35:100008. PubMed Abstract available
PLANTE M, Mahner S, Sebastianelli A, Bessette P, et al Minimally invasive compared to open surgery in patients with low-risk cervical
cancer following simple hysterectomy: An exploratory analysis from the
Gynegologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial.
Int J Gynecol Cancer. 2025;35:100001. PubMed Abstract available
YARZA R, Kountouri M, Guedes H, O'Gorman C, et al Progression-free survival as a potential surrogate end point for overall survival
in advanced cervical carcinoma.
Int J Gynecol Cancer. 2025;35:100012. PubMed Abstract available
MILLER KM, Liu C, Zhou Q, Iasonos A, et al RELEVANT-C study: patient-reported prevalence of lower extremity lymphedema after
sentinel lymph node mapping vs lymphadenectomy after surgery for early-stage
cervical cancer.
Int J Gynecol Cancer. 2025;35:100063. PubMed Abstract available
TSIBULAK I, Collins A, Hsu HC, Chacon E, et al Global survey on training and practice in sentinel lymph node mapping for
endometrial and cervical cancer among early-career gynecologic oncologists.
Int J Gynecol Cancer. 2025;35:100050. PubMed Abstract available
DITTO A, Dri M, Leone Roberti Maggiore U, Raspagliesi F, et al Reply to "Correspondence on 'Fertility-sparing treatment with conization versus
radical hysterectomy in patients with early-stage cervical cancer: Inverse
propensity score-weighted analysis,' by Ditto et al" by Phillippe Morice and
Sebastien Gouy.
Int J Gynecol Cancer. 2025;35:100026. PubMed
LIEN CJ, Lien WC Wunderlich syndrome as a presenting symptom in cervical cancer.
Int J Gynecol Cancer. 2025 Jan 30:101675. doi: 10.1016/j.ijgc.2025.101675. PubMed
LEETANAPORN K, Hanprasertpong J Addition of chemotherapy to radiation is associated with improved survival in
older patients with cervical cancer: a Surveillance, Epidemiology, and End
Results database analysis.
Int J Gynecol Cancer. 2025 Jan 9:101633. doi: 10.1016/j.ijgc.2025.101633. PubMed Abstract available
BOGANI G, Scambia G, Malzoni M, Casarin J, et al Chemo-conization in Early-sTage cERvical caNcer >2 cm scheduled for
fertilItY-sparing approach: an analysis of the ETERNITY project.
Int J Gynecol Cancer. 2025 Jan 17:101643. doi: 10.1016/j.ijgc.2025.101643. PubMed Abstract available
MURATA K, Okonogi N, Ando K, Tsuchida K, et al Carbon-ion radiotherapy for adenocarcinoma of the uterine cervix: clinical
outcomes of a multicenter prospective registry-based study in Japan (2016-2020).
Int J Radiat Oncol Biol Phys. 2024 Oct 16:S0360-3016(24)03467. PubMed Abstract available
GAO H, Wu H, Zhang Y, Wang S, et al Dose-volume constraints for severe acute gastrointestinal toxicity in cervical
cancer patients receiving extended-field intensity-modulated radiotherapy and
concurrent chemotherapy.
Radiother Oncol. 2025 Feb 4:110777. doi: 10.1016/j.radonc.2025.110777. PubMed Abstract available
JAIN J, Serban M, Assenholt MS, Hande V, et al Can knowledge-based planning models validated on ethnically diverse patients lead
to global standardisation of external beam radiation therapy for locally advanced
cervix cancer?
Radiother Oncol. 2025;204:110694. PubMed Abstract available
PINTO-SANTINI D, Jalil EM, Fernandes GT, Hilaire G, et al ULACNet-301, OPTIMO protocol: optimizing HPV vaccination regimen for cancer
prevention in children and adolescents living with HIV.
BMC Cancer. 2025;25:151. PubMed Abstract available
SWASE TD, Fasogbon IV, Eseoghene IJ, Etukudo EM, et al The impact of HPV/HIV co-infection on immunosuppression, HPV genotype, and
cervical cancer biomarkers.
BMC Cancer. 2025;25:202. PubMed Abstract available
ANANGWE N, Steimgrimson J, Cu-Uvin S Evaluation of pathology resources for cervical cancer detection between 2018 and
2022: a retrospective study at Moi Teaching and Referral Hospital, Western Kenya.
BMC Cancer. 2025;25:203. PubMed Abstract available
MA H, Ma L, Yang L, Cai M, et al Construction and evaluation of a prognostic model for cervical cancer based on
dynamic hematological and clinical features.
BMC Cancer. 2025;25:207. PubMed Abstract available
BEHERY MB, Bahbah AA, Mohamed Shawqi M, El-Said YM, et al Knowledge, attitude, and practice towards uterine cervical cancer screening in
Egyptian females: a nationwide cross-sectional study.
BMC Cancer. 2025;25:237. PubMed Abstract available
WANG Y, Yu Y, Gu L, Sun Y, et al Radiomics feature is a risk factor for locally advanced cervical cancer treated
using concurrent chemoradiotherapy based on magnetic resonance imaging: a
retrospective study.
BMC Cancer. 2025;25:230. PubMed Abstract available
ZHOU K, Wang C, Zhao J, Chen J, et al Dosimetric effects of bladder volume changes in MR-guided radiotherapy for
cervical cancer.
BMC Cancer. 2025;25:324. PubMed Abstract available
BA-ALAWI E, Azzani M, Alsaidi NA, Atroosh WM, et al Correction: Barriers to cervical cancer screening among immigrant Yemeni women in
Malaysia.
BMC Cancer. 2025;25:320. PubMed
OKYERE J Multiple sexual partnership as an independent predictor of cervical cancer
screening among women of reproductive age: an analysis of the 2022 Kenya
demographic and health survey.
BMC Cancer. 2025;25:259. PubMed Abstract available
ASIRWA FC, Bresnahan BW, Yego F, Duncan D, et al A prospective model of the potential clinical and economic impact of cervical
cancer screening supported by a mobile phone app.
PLoS One. 2025;20:e0316001. PubMed Abstract available
DEMEKE AD, Deribe B, Girma M, Gizaw M, et al Screening attendance of breast or cervical cancers and its associated factors
among 30-49 year old women in Gedeo zone, South Ethiopia: Cross-sectional study.
PLoS One. 2025;20:e0315891. PubMed Abstract available
UM S, Sopheab H Breast and cervical cancer screening among women at reproductive age in Cambodia:
A secondary analysis of Cambodia Demographic and Health Survey 2022.
PLoS One. 2025;20:e0295881. PubMed Abstract available
Retraction: Long Noncoding RNA-EBIC Promotes Tumor Cell Invasion by Binding to
EZH2 and Repressing E-Cadherin in Cervical Cancer.
PLoS One. 2025;20:e0318789. PubMed
OPITO R, Tiyo Ayikobua E, Akurut H, Alwedo S, et al Factors associated with uptake and acceptability of cervical cancer screening
among female sex workers in Northeastern Uganda: A cross-sectional study.
PLoS One. 2025;20:e0312988. PubMed Abstract available
GAO Y, Liang G, Chang C, Pan F, et al Analysis of cervical and breast cancer screening behavior and its influencing
factors among urban and rural women in Beijing.
PLoS One. 2025;20:e0316898. PubMed Abstract available
WAGNER GJ, Bogart LM, Matovu JKB, Gwokyalya V, et al Study protocol for a hybrid implementation-effectiveness trial of Game Changers
for Cervical Cancer Prevention in Uganda.
PLoS One. 2025;20:e0317491. PubMed Abstract available
PANERU B, Karmacharya A, Bharati A, Makaju S, et al Correction: Association between cancer stigma and cervical cancer screening
uptake among women of Dhulikhel and Banepa, Nepal.
PLoS One. 2025;20:e0318367. PubMed Abstract available
AYTAC S, Ozbey G Photodiagnosis and photodynamic recognition of cervical cancer with SEM and AFM
images.
PLoS One. 2025;20:e0316544. PubMed Abstract available
HAMZA MN, Tariqul Islam M, Lavadiya S, Ud Din I, et al Design and validation of ultra-compact metamaterial-based biosensor for
non-invasive cervical cancer diagnosis in terahertz regime.
PLoS One. 2025;20:e0311431. PubMed Abstract available
MALOBA M, Finocchario-Kessler S, Wexler C, Staggs V, et al The Cancer Tracking System (CATSystem): Study protocol of a randomized control
trial to evaluate a systems level intervention for cervical cancer screening,
treatment, referral and follow up in Kenya.
PLoS One. 2025;20:e0318941. PubMed Abstract available
